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RNA editing in kinetoplastid mitochondria inserts and deletes uridylates at multiple sites in pre-mRNAs as
directed by guide RNAs. This occurs by a series of steps that are catalyzed by endoribonuclease, 3*-terminal
uridylyl transferase, 3*-exouridylylase, and RNA ligase activities. A multiprotein complex that contains these
activities and catalyzes deletion editing in vitro was enriched from Trypanosoma brucei mitochondria by sequen-
tial ion-exchange and gel filtration chromatography, followed by glycerol gradient sedimentation. The complex
size is approximately 1,600 kDa, and the purified fraction contains 20 major polypeptides. A monoclonal
antibody that was generated against the enriched complex reacts with an ;49-kDa protein and specifically im-
munoprecipitates in vitro deletion RNA editing activity. The protein recognized by the antibody was identified
by mass spectrometry, and the corresponding gene, designated TbMP52, was cloned. Recombinant TbMP52
reacts with the monoclonal antibody. Another novel protein, TbMP48, which is similar to TbMP52, and its gene
were also identified in the enriched complex. These results suggest that TbMP52 and TbMP48 are components
of the RNA editing complex.
Several mitochondrial RNAs are posttranscriptionally ed-
ited in kinetoplastid protozoa by the insertion and deletion of
uridylates (U’s) at multiple sites, to produce mature mRNAs.
RNA editing creates initiation and termination codons and the
likely functional open reading frames (ORFs). Indeed, trans-
lation of edited RNA has recently been directly demonstrated
(11). The RNA editing appears to regulate mitochondrial res-
piration in different life cycle stages of Trypanosoma brucei.
The insertion and deletion of U’s is directed by small RNAs
that are called guide RNAs (gRNAs). The editing occurs by a
series of enzymatic steps. These steps include gRNA-directed
cleavage of the pre-mRNA by endoribonuclease, U addition or
removal at the 39 end of the 59 cleavage product by 39-terminal
uridylyl transferase (TUTase) or 39-exouridylylase, respec-
tively, and ligation of 59 and 39 cleavage products by RNA
ligase (reviewed in references 6, 13, and 28).
RNA editing occurs in association with a ribonucleoprotein
complex which sediments at 20S in glycerol gradients (4, 22).
Fractionation and hence partial purification of the complex by
glycerol gradient and liquid chromatographic techniques have
been reported (4, 18, 22, 24). For the most part, these prepa-
rations were insufficient to identify specific proteins that are
part of the editing complex. However, Rusche´ et al. (24) sug-
gested that a complex of eight proteins could catalyze editing.
They concluded that three of these proteins were adenylylat-
able and suggested that they represented the editing RNA
ligase, although the role of these proteins has not yet been
demonstrated. Indeed, little progress has been made on the
definitive identification of proteins that are components of the
editing complex. Three T. brucei mitochondrial proteins, gBP21
(15), DEAD box protein mHEL61p (19), and REAP1 (18),
were identified as candidate components of the editing com-
plex. In addition, two T. brucei mitochondrial poly(U) binding
proteins, TBRGG1 (30) and RBP16 (10), were identified and
suggested to have a role in RNA editing. Knockout of both
gBP21 alleles (i.e., null mutations) had no effect on RNA edit-
ing in bloodstream-form T. brucei in vivo, indicating that gBP21 is
not essential for editing (16). However, knockout of both
mHEL61 alleles resulted in slow-growing insect procyclic
forms. These cells are capable of in vitro editing but have a
.70% reduction in edited mRNAs in vivo, which is restored
upon reexpression of mHEL61p (19). These data suggest that
mHEL61p may be a component of the editing complex, al-
though not an essential one. Similar assays of the other can-
didate editing complex proteins have not yet been published.
The difficulty in identifying the protein components of the
RNA editing complex reflects the apparent low cellular abun-
dance of the complex, the low sensitivity of the in vitro editing
assays, and the uncertainty that assays of endonuclease, exo-
nuclease, TUTase, and RNA ligase are specific for activities
associated with the intact complex. These factors, in addition
to contamination from protein adsorption during fraction-
ation, made protein identification by conventional microse-
quencing difficult. However, mass spectrometric analysis has
been useful for identifying proteins that are present in small
amounts and in mixtures of proteins (17). It was successfully
used to identify components of multiprotein complexes, such
as the U1 snRNP from the yeast Saccharomyces cerevisiae (21).
Indeed, in organisms where the complete genome sequence is
available, mass spectrometry can be used to identify the gene
for virtually any protein that can be visualized by conventional
staining methods. Few genomic sequence data were available
for T. brucei until recently, as sequence data from the genome
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sequencing projects have been accumulating rapidly in the
databases.
In this study, we report the biochemical fractionation of the
RNA editing complex from T. brucei mitochondria. The frac-
tionation was monitored using the in vitro deletion editing
assay in an attempt to purify the complex that is capable of all
steps of editing. The editing complex was isolated by sequential
ion-exchange and gel filtration chromatography followed by
sedimentation on a glycerol gradient. Two novel related pro-
teins in the most purified fraction and their genes were iden-
tified using capillary liquid chromatography-tandem mass spec-
trometry (LC-MS/MS) and by comparison to the T. brucei
genome sequence database. They were designated TbMP52
and TbMP48, based on the predicted mass of the preprocessed
protein. One monoclonal antibody (MAb) from a panel that
was generated against the isolated complex was specific for
TbMP52 in Western analyses of native and recombinant pro-
tein. This MAb also immunoprecipitated the in vitro deletion
editing activity. These data strongly suggest that TbMP52 and
TbMP48 are components of the editing complex.
MATERIALS AND METHODS
Cell growth and isolation and fractionation of mitochondrial proteins. T.
brucei procyclic forms (strain IsTaR 1.7a) were grown to log phase in vitro as
described previously (29). The mitochondrial vesicles were isolated (9) and
stored at 270°C. Mitochondria from 5.1 3 1011 cells were lysed in 55 ml of buffer
SP-A (10 mM Tris [pH 7.0], 10 mM MgCl2, 50 mM KCl, 1 mM dithiothreitol
[DTT]) containing the protease inhibitors leupeptin (10 mg/ml), pepstatin (5
mg/ml), and Pefablock (1 mM). The lysis was carried out using 0.5% Triton X-100
for 15 min at 4°C with bidirectional mixing. The lysate was cleared by centrifu-
gation at 17,500 3 g for 30 min at 4°C. The cleared lysate was filtered through
0.2-mm-pore-size membranes and loaded onto a 10-ml SP Sepharose HR column
(Pharmacia) at a 1-ml/min flow rate. All chromatographic steps were carried out
using an automated fast protein liquid chromatography system (LKB-Pharma-
cia) at 4°C. The unbound proteins were washed away with 5 column volumes of
buffer SP-A. The bound proteins were eluted with 80 ml of a linear salt gradient
of 50 to 330 mM KCl, followed by an 80-ml linear gradient to 1 M KCl at a
2-ml/min flow rate. Fractions of 4 ml were collected and assayed for in vitro
deletion RNA editing activity. All positive fractions (9 to 19) were pooled and
further fractionated on a Q Sepharose column. Two HiTrap Q 1-ml columns
(Pharmacia) were joined in series and equilibrated with buffer Q-A (10 mM Tris
[pH 8.3], 10 mM MgCl2, 50 mM KCl, 1 mM DTT). The pooled fractions from the
SP Sepharose column were diluted and pH adjusted to the same conditions as
buffer Q-A. The sample was loaded onto a Q Sepharose column at a 1-ml/min
flow rate, and unbound proteins were washed away with 5 column volumes of
buffer Q-A. The elution was carried out with 16 ml of linear salt gradient to 330
mM KCl, followed by a 14-ml linear gradient to 1 M KCl, at a 0.5-ml/min flow
rate. Fractions of 1 ml were collected and assayed for deletion RNA editing
activity. The positive fractions (11 to 20) were pooled, and Triton X-100 was
added to a final concentration of 0.1%. The sample was concentrated to 1/10
volume using Centricon-YM50 membrane (Amicon) at 3,000 3 g. The proteins
were size fractionated with a Superose 6 HR (10/30) column (Pharmacia). In
each run a 250-ml sample was loaded onto the column at a 0.2-ml/min flow rate
(the buffer was 10 mM Tris [pH 7.0], 10 mM MgCl2, 200 mM KCl, and 1 mM
DTT). Fractions of 500 ml were collected and assayed for deletion RNA editing.
The size of the complex in the peak editing fraction was estimated in comparison
to globular protein size standards (gel filtration high-molecular-weight calibra-
tion kit; Pharmacia). The peak positive fractions (19 to 22) were pooled and
concentrated as described above and sedimented on a 10-to-30% linear glycerol
gradient. An 11-ml linear gradient was prepared in 10 mM Tris [pH 7.0]–10 mM
MgCl2–100 mM KCl, and 500 ml of sample was layered on top of it. After cen-
trifugation at 38,000 rpm for 5 h at 4°C (SW40 rotor; Beckman), 500-ml fractions
were collected from the top and assayed for deletion RNA editing activity.
In vitro deletion editing. The in vitro deletion editing assay was carried out
using 39-labeled A6-U5 pre-mRNA substrate and gA6[14]D16G gRNA as de-
scribed previously (26). The reaction was carried out for 2 h in a 30-ml final
volume using 4 to 8 ml of test sample. Reaction products were run on 9%
polyacrylamide–7 M urea gels and were detected with a Storm PhosphorImager
screen (Molecular Dynamics). Quantification was performed with ImageQuaNT
software.
MAb. The RNA editing complex was fractionated in three batches as de-
scribed above, from a total of 1.64 3 1012 cells. The peak editing fractions from
glycerol gradients were pooled and concentrated using a Centricon-YM50 mem-
brane and used as immunogens. MAbs were produced at Biologics Production
Facility, Fred Hutchinson Cancer Research Center, Seattle, Wash. Supernatants
from hybridomas were screened for production of antibody against the editing
complex (sequentially fractionated by SP Sepharose, Q Sepharose, and Superose
6 columns) using the enzyme-linked immunosorbent assay (ELISA). All ELISA-
positive samples were screened by Western blot analysis using SP and Q Sepha-
rose-fractionated editing complexes as the antigens. The contents of 15 ELISA-
and Western blot-positive hybridoma wells were subcloned by dilution. The super-
natants were screened for MAb production by both ELISA and Western analy-
ses.
Western blot analysis. RNA editing complex that was partially purified by SP
and Q Sepharose chromatography as described above was used as the antigen for
Western analysis. One microgram of protein sample was separated by sodium
dodecyl sulfate–10% polyacrylamide gel electrophoresis (SDS-PAGE) and trans-
ferred onto a nitrocellulose filter. The filter was blocked overnight with 5%
nonfat milk powder in PBST (10 mM phosphate buffer [pH 7.2], 150 mM NaCl,
0.05% Tween 20) at 4°C. It was washed three times with PBST and incubated
with tissue culture supernatant diluted 1:100 in PBST. The incubation was car-
ried out at room temperature for 2 h with gentle shaking. The filter was washed
three times with PBST and incubated for 1 h with horseradish peroxidase-
conjugated anti-mouse immunoglobulin G (IgG) (Bio-Rad) at a 1:2,000 dilution
in PBST. The filter was washed four times with PBST and developed with an
ECL kit (Amersham) according to the manufacturer’s instructions. To assay the
distribution of TbMP52 in the glycerol gradient, 5 ml of sample from each
fraction was separated on an SDS-PAGE gel and examined by Western analysis.
Immunoprecipitation of editing complex. Immunomagnetic beads (Dynabeads
M-450; Dynal) coated with goat anti-mouse IgG were coupled to MAbs from
tissue culture supernatants. A total of 4 3 107 beads were incubated with 1 ml of
tissue culture supernatant and 1% bovine serum albumin at 4°C with bidirec-
tional mixing for 1 h. The beads were washed three times with immunoprecipi-
tation buffer (IP buffer; 10 mM Tris [pH 7.2], 10 mM MgCl2, 200 mM KCl, 0.1%
Triton X-100). The mitochondria were lysed in IP buffer with 0.5% Triton X-100,
cleared by centrifugation, and fractionated on a 10-to-30% glycerol gradient as
described above. The antibody-bound beads were incubated with the mitochon-
drial 20S fraction (50 mg of proteins) in 13 IP buffer and 1% bovine serum
albumin for 1 h at 4°C with bidirectional mixing. The beads were washed four
times (each wash of 5 min duration with bidirectional mixing) with IP buffer and
twice with buffer containing 25 mM HEPES (pH 7.9), 10 mM magnesium acetate
[Mg(OAc)2], 50 mM KCl, 1 mM EDTA, and 0.1% Triton X-100 and directly
assayed for deletion editing and adenylylatable proteins. Similarly, immunopre-
cipitation experiments were carried out with IP buffer containing 300 or 400 mM
KCl, and beads were assayed for deletion editing and adenylylatable proteins. In
addition, the mitochondrial 20S fraction was first adenylylated with [a-32P]ATP
and immunoprecipitated as described above with IP buffer containing 400 mM
KCl.
Adenylylation. The presence of the adenylylatable proteins in the samples was
determined as described earlier (25), with some modifications. Adenylylation
reactions were carried out with 2.5 mCi of [a-32P]ATP in buffer containing 25
mM HEPES (pH 7.9), 10 mM Mg(OAc)2, 50 mM KCl, 0.5 mM DTT, and 10%
dimethyl sulfoxide for 15 min at 28°C. The proteins were separated by SDS-
PAGE, and radiolabeled proteins were detected by phosphorimaging.
Identification of proteins. The proteins were separated on an SDS-PAGE gel
(20 cm long) and visualized either by silver nitrate or Coomassie blue staining.
The protein bands were excised from the gel, and in-gel tryptic digestion was
carried out as described previously (27). The tryptic peptides were analyzed by
microcapillary LC-MS with automated switching to MS/MS mode for peptide
fragmentation and sequence analysis (7). The collision-induced dissociation
(CID) spectra were compared with the OWL nonredundant protein sequence
database and then with a trypanosome nucleotide database. The database in-
cluded Trypanosoma genomic and expressed sequence tag sequences from the
National Center for Biotechnology Information database and from The Institute
for Genomic Research (http://www.tigr.org) and Sanger Center (http://www
.sanger.ac.uk) genome sequencing projects. The search was carried out against
all six ORFs for nucleotide sequences using the SEQUEST program, which
matches theoretical and acquired tandem mass spectra (31). A protein match was
determined from the number of identified peptides, their cross-correlation
scores, and their predicted theoretical molecular weights compared to migration
in the gel.
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Cloning and expression of TbMP52 and TbMP48. The entire ORF represent-
ing TbMP52 was amplified from genomic DNA with primers Tb10-2261P (ACT
GCA GAT GCA ACT CCA AAG G) and Tb10-3690M (AGA ATT CGC AGT
AT CAT TCG CC) (the restriction sites are italicized). The amplified DNA was
cloned into the pGEM-T easy vector (Promega), and the sequence was con-
firmed. The insert was released with PstI and EcoRI enzymatic digestion and
cloned into the pRSET C vector (Invitrogen) cut with the same enzymes. Sim-
ilarly, the TbMP48 ORF was PCR amplified with the primer pairs Tb07-1423P
(TGG ATC CTG AAG ATG TTG CGT C) and Tb07-2679M (AGG TAC CAT
TCG CTA AAG TCA GG) and cloned into the pRSET C vector at the BamHI-
KpnI site. The plasmids were transformed into BL21 DE3-LysS cells, and re-
combinant proteins were expressed with 1 mM IPTG (isopropyl-b-D-thiogalac-
topyranoside) induction. The Escherichia coli cells expressing recombinant
proteins were separated by SDS-PAGE and either stained with Coomassie blue
or transferred onto nitrocellulose paper. These were reacted with individual
MAb supernatants (1:100 dilution) as described above. E. coli cells transformed
with vector only were used as negative controls.
Subcellular localization of TbMP52 by immunofluorescence. Procyclic-form
trypanosomes were fixed onto microscope slides, and immunofluorescence reac-
tions were carried out as previously described (1). Briefly, the cells were incu-
bated with MAb P3C1-G2 (tissue culture supernatant diluted 1:10 in 13 phos-
phate-buffered saline [PBS]) for 1 h, washed, and incubated with fluorescein
isothiocyanate-conjugated goat anti-mouse IgG (diluted 1:200 in PBS) for 1 h.
The washed cells were treated with 4,6-diamidino-2-phenylindole (DAPI; 0.5
mg/ml in PBS) to stain DNA. Fluorescence was observed with a Nikon fluores-
cence microscope equipped with the appropriate filters.
Nucleotide sequence accession numbers. The nucleotide and protein se-
quences have been submitted to GenBank and SWISS-PROT with accession
numbers AY009110, AY009111, P82863, and P82864.
RESULTS
Enrichment of RNA editing complex. The RNA editing com-
plex was enriched from T. brucei mitochondrial lysate by se-
quential fractionation by two ion-exchange columns, a gel fil-
tration column, and glycerol gradient sedimentation (Fig. 1).
The fractionation of the functional complex was monitored
using the in vitro assay for deletion editing (26). The peak of in
vitro editing activity from cleared mitochondrial lysate, which
was prepared as described in Materials and Methods, eluted
from the SP Sepharose (cation-exchange) column at about 200
mM KCl (Fig. 1A). Similarly, the peak of the editing activity
from the pooled SP Sepharose fractions containing the editing
activity eluted from the Q Sepharose (anion-exchange) column
at about 225 mM KCl (Fig. 1B). There was no detectable
editing activity in the fractions that did not bind to these
columns. The editing activity from the pooled active fractions
from the Q Sepharose column eluted from the Superose 6 (gel
filtration) column with a peak which centered at an elution
FIG. 1. Fractionation of RNA editing complex from T. brucei mitochondria. In vitro deletion RNA editing was used as the functional assay to
monitor purification of the complex. (A) Cleared mitochondrial lysate prepared with 0.5% Triton X-100 was fractionated on an SP Sepharose
column. (B and C) Fractions containing editing activity, as indicated by the dark lines below each panel, were sequentially fractionated on Q
Sepharose (B) and Superose 6 (C) columns. (D) The complex was further purified by sedimentation on a 10-to-30% glycerol gradient, with fraction
1 being the top of the gradient. Diamonds, deletion editing; dotted line, absorbance at 280 nm; dashed line, KCl gradient profile (the KCl
concentration [molar units] is the value on the righthand y axis divided by 10).
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position corresponding to about 1,600 kDa compared to glob-
ular protein size standards (Fig. 1C and data not shown). The
buffer used for size fractionation on the Superose 6 column
contained 200 mM KCl in order to avoid nonspecific associa-
tion of other proteins with the editing complex. We observed
that the complex eluted from Superose 6 with the same appar-
ent mass when a buffer containing up to 300 mM KCl was used.
However, it eluted with a greater apparent mass (in void vol-
ume) with a buffer containing 50 mM KCl (data not shown),
perhaps indicating its association with other proteins or com-
plexes or self aggregation. The pooled peak of deletion editing
activity from the Superose 6 column, as well as the bulk of the
total protein (see Fig. 2), sedimented with a peak centered at
;20S on a 10-to-30% glycerol gradient (Fig. 1D). The frac-
tions containing the editing activity represent about 1/8,500 of
the protein in the original cleared mitochondrial lysate. The
fractions positive for RNA editing contained precleaved inser-
tion editing (12), endonuclease (8), TUTase (4), 39-exouridyl-
ylase, and RNA ligase activities, as well as adenylylatable pro-
teins (25) (results not shown). Northern analysis revealed the
presence of gRNAs and preedited mRNAs in the peak editing
fraction isolated by sequential ion-exchange and gel filtration
chromatography (results not shown).
The protein profiles of the pooled active fractions from each
column and from the glycerol gradient fractions were analyzed
by electrophoresis in SDS-PAGE followed by silver staining
(Fig. 2). The protein profiles from each pooled fraction from
the columns were substantially different from each other and
showed a progressively simpler pattern. This is consistent with
the absorbance profiles from the columns, which indicate that
most of the proteins that are not associated with the editing
activity were eliminated. The profile of the pooled fractions
from the Superose 6 column was very similar to that of the
glycerol gradient fractions that showed the greatest editing
activity. Examination of glycerol gradient fraction 7, which
contains the greatest editing activity, reveals 20 major polypep-
tides with apparent masses of 20, 22, 29, 34, 42, 43, 44, 45, 47,
49, 50, 53, 55, 57, 69, 72, 90, 99, 106, and 114 kDa. While the
22-, 44-, and 90-kDa protein bands stained more intensely than
the other proteins, this may or may not reflect the ratio of the
proteins in the complex, since different proteins stain at dif-
ferent intensities with silver nitrate. In addition, editing was
not detected in fractions 2 to 4, although many of these 20
proteins were present, and there was more editing in fraction
9 than in fraction 5, although it had less protein (Fig. 1D and
2). Perhaps there is a smaller proportion of complete (i.e., fully
functional) complexes in the upper (lower sedimentation
value) fractions than in fraction 9.
Immunoprecipitation of editing complex using MAbs. A
panel of MAbs was generated using the enriched complex as
the immunogen, to generate reagents that are specific to com-
ponents of the editing complex and that can be used to identify
and characterize these components. A total of 19 independent
MAbs were isolated, and they were directed against seven
different proteins, based on Western analyses. One MAb,
P3C1-G2, reacted with an ;49-kDa protein in Western anal-
yses and immunoprecipitated in vitro deletion editing activity
(Fig. 3A and B). The immunoprecipitations and washes were
performed with the 20S fraction of glycerol gradient-fraction-
ated mitochondrial lysate using 0.1% nonionic detergent and
either 200, 300, or 400 mM KCl (to reduce nonspecific asso-
ciations) as described in Materials and Methods. The editing
activity did not immunoprecipitate with MAb 58 (Fig. 3B, lane
2), which is directed against the T. brucei mitochondrial pyru-
vate dehydrogenase E2 subunit (reference 1 and unpublished
results) or with MAb P7D9-A12, which reacts with a protein in
an unidentified 40S complex. Even material that was immuno-
precipitated with 400 mM KCl was able to catalyze in vitro
editing, although the activity was reduced by 30% compared to
the activity of the material that was immunoprecipitated with
200 mM KCl (Fig. 3B, lane 4). The immunoprecipitated ma-
terial also contained component editing activities (precleaved
insertion editing, endonuclease, TUTase, 39-exouridylylase,
and RNA ligase activities [results not shown]). This demon-
strates that MAb P3C1-G2 can immunoprecipitate the active
editing complex.
We also tested the ability of MAb P3C1-G2 to immunopre-
cipitate the 50- and 57-kDa adenylylatable proteins, which
were reported to be RNA ligases with a possible role in RNA
editing (25). These proteins were also reported to cofraction-
ate with editing activities (18, 24). The material that was im-
munoprecipitated by MAb P3C1-G2 contained two adenyly-
latable proteins (Fig. 3C). In addition, MAb P3C1-G2 was able
to immunoprecipitate two proteins that were adenylylated
prior to the immunoprecipitation, even in buffer containing
400 mM KCl and 0.1% Triton X-100 (Fig. 3D). Essentially no
adenylylatable proteins or preadenylylated proteins immuno-
precipitated with MAb 58 (1), which was used as the negative
FIG. 2. SDS-PAGE profile of fractions from complex purification.
A sample from each step of purification was separated by SDS-PAGE
and stained with silver nitrate. Results for protein size standards (M),
cleared mitochondrial lysate (Cr), and pooled editing activity-positive
fractions from SP Sepharose (SP), Q Sepharose (Q), and Superose 6
(S6) columns are presented. Glycerol gradient fractions 1 to 10 (frac-
tion 1 is at the top) are shown (fractions 11 to 23 are not shown since
essentially no protein was detected in these fractions). The numbers on
left indicate the sizes of molecular mass markers, in kilodaltons. The
most purified editing activity-positive fraction from the glycerol gradi-
ent (7) shows 20 major polypeptide bands.
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control. Unlike the data in earlier reports, the major adenyly-
latable and preadenylylated proteins had apparent sizes of 44
and 50 kDa. Western analysis with MAb P3C1-G2 of fractions
from a 10-to-30% glycerol gradient of mitochondria that were
lysed in buffer with 200 mM KCl showed the bulk of the
49-kDa protein sediments at ;20S, similar to the deletion
editing activity (Fig. 1D and 3E).
Identification of TbMP52 and TbMP48 proteins. The 49-
kDa protein that reacts with MAb P3C1-G2 and its corre-
sponding gene were identified by a combination of high-per-
formance LC-MS/MS and analyses of T. brucei genome
sequence data. Mass spectrometric analyses were performed
on both the fraction containing the editing complex and on
individual bands that were cut from SDS-PAGE gels (e.g., Fig.
2, lanes S6 and 7). LC-MS/MS is highly sensitive and can allow
identification of proteins in mixtures (17). Protein was digested
in gel with trypsin, and the resulting peptides were fractionated
by on-line capillary liquid chromatography and eluted directly
into the mass spectrometer, where they were analyzed. Peptide
masses and amino acid sequences were determined by auto-
mated selection and fragmentation of specific ionized peptides.
This entailed switching between MS and MS/MS modes and
resulted in the CID MS/MS spectrum of each peptide. Indi-
vidual CID spectra were compared to predicted spectra from
sequence databases by using computer algorithms to identify
the gene and hence the protein. This analysis identified mul-
tiple peptides that corresponded to multiple CID MS/MS spec-
tra from the same protein.
An example of a CID spectrum of a peptide that corre-
sponds to a tryptic peptide with the amino acid sequence VH
GTNFGIYLINQGDHEVVR from the 49-kDa protein is
shown in Fig. 4A. The results of a database search that com-
pared this CID spectrum with CID spectra predicted from
Trypanosoma sequences are shown in Table 1. This search
identified a candidate matching peptide sequence in a 1,410-
nucleotide ORF in The Institute for Genomic Research T. bru-
cei genome sequencing project database. The confidence level
for this match (at positions 50,980 to 52,389; accession no.
FIG. 3. Immunoanalysis of the editing complex using a MAb. (A)
MAb P3C1-G2 raised against the purified complex reacts with an
;49-kDa protein in Western analysis of a partially purified complex.
(B) MAb P3C1-G2 specifically immunoprecipitates editing activity
from the 20S mitochondrial fraction (see Materials and Methods for
details) (lanes 3 and 4). Edited RNA, chimeras, and 39 cleavage prod-
ucts and the input RNA from which they are derived are indicated.
MAb 58 (1), the negative control, did not immunoprecipitate these
activities (lane 2). Editing activity immunoprecipitated with 200 and
400 mM KCl (lanes 3 and 4, respectively). The positive deletion editing
control using the mitochondrial 20S fraction is also shown (lane 1). (C)
MAb P3C1-G2 immunoprecipitates both 50- and 44-kDa adenylylat-
able proteins. MAb 58, which was used as a negative control, essentially
did not immunoprecipitate the adenylylation activity. The control (1ve)
for these proteins using the mitochondrial 20S fraction is shown. (D)
MAb P3C1-G2 also immunoprecipitated both the 50- and 44-kDa pro-
teins from the mitochondrial 20S fraction in a buffer containing 400 mM
KCl following their adenylylation. (E) Western analysis of glycerol gradi-
ent-fractionated cleared mitochondrial lysate using MAb P3C1-G2.
FIG. 4. Identification of TbMP52. (A) Sample tandem mass spec-
trum derived by CID of a peptide precursor ion, m/z 1135.0 (bottom),
and the peptide sequence predicted by SEQUEST (top) showing b-
and y-type ions (above and below the sequence, respectively). (B)
Amino acid sequence of the complete ORF identified by 11 tryptic
peptide matches with CID spectra. The identified peptides are under-
lined (at two different positions, two and three peptides were contig-
uous). The dashed underline indicates the probable N-terminal pep-
tide in the mature protein that is nontryptic, and the double underline
indicates the peptide with the highest correlation score (Table 1). The
predicted mitochondrial targeting signal is italicized.
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7330318 and AC013484.9 [GenBank]; chromosome IX clone
RPCI93-1L12) was quite high. Similar analyses identified 10
additional tryptic peptides with matches to this ORF (Fig. 4B).
Thus, the probability that this gene corresponds to the 49-kDa
protein is very high. The protein predicted from the ORF has
a mass of 52 kDa, but its N-terminal sequence has an am-
phiphilic helix that is predicted by Gene Runner (Hastings
Software, Inc.) and a mitochondrial targeting signal that is
predicted by the PSORT II algorithm (http://psort.ims.u-to-
kyo.ac.jp/form2.html). In addition, the CID spectrum of a pep-
tide from the 49-kDa protein identified the peptide (T)YM-
PLPNDQSDFSPYIEIDLPSESR from this ORF (Fig. 4B).
The N-terminal amino acid Y in the peptide could be gener-
ated if in vivo processing removed the signal peptide, and the
amino acid T, being nontryptic, may be part of the signal
peptide. These data are consistent with localization of the
49-kDa protein within the mitochondrion after cleavage of the
mitochondrial signal peptide. The protein is designated
TbMP52, for “T. brucei mitochondrial protein,” and has a
preprocessed molecular mass of 52 kDa; the gene is designated
TbMP52. The first 44 amino acids in the N-terminal region may
form a signal peptide, and this predicts a 48-kDa mature pro-
tein, which is consistent with its apparent migration size of 49
kDa. Immunofluorescence analysis with MAb P3C1-G2
showed staining of the mitochondrion, indicating that TbMP52
is localized in this organelle (Fig. 5).
Another gene that is related to TbMP52 and its correspond-
ing protein, which copurifies with the editing activity, were
identified by a combination of mass spectrometry and database
analyses (Fig. 6). A search of the Sanger Center T. brucei ge-
nome project database identified a 1,251-nucleotide ORF (po-
sitions 98742 to 97492 of contig TRYP1.0.7383 of chromosome
I) that has significant homology to TbMP52 (Fig. 6A). This
ORF encodes a 48-kDa protein, and similar to TbMP52, the
N-terminal sequence of the 48-kDa protein predicts a mito-
chondrial targeting signal sequence. There is a deletion/inser-
tion site near the N terminus of TbMP48 relative to TbMP52
that appears to be located within the signal peptide. LC-
MS/MS analysis of an ;44-kDa protein from the SDS-PAGE
gel (Fig. 2, lane 7) identified 13 peptides that correspond to
peptides predicted from this ORF (Fig. 6B). A peptide with
the amino acid sequence (F)VGGDGSIFER was identified
from near the N terminus of the predicted protein (Fig. 6B and
C and Table 2). The amino acid (F) N-terminal to V, since it
is not tryptic, may be part of the mitochondrial targeting signal.
Thus, the first 17 amino acids, which also can fold into an
amphiphilic helix (results not shown), are predicted to form
the mitochondrial targeting signal. Hence, this second protein,
designated TbMP48, also appears to be localized in the mito-
chondrion after removal of the signal peptide, resulting in a
45-kDa mature protein. The mature TbMP48 migrates as an
;44-kDa band in SDS-PAGE gels.
Additional BLAST searching of the National Center for
Biotechnology Information database revealed that the Leish-
mania major gene L5701.8 (accession no. AAC24666 [20]) has
significant homology to TbMP52 at both the nucleic acid and
predicted amino acid sequence levels, while the relationship of
TbMP48 to TbMP52 is evident only at the predicted amino
acid sequence level. L5701.8 has 66% identity and 78% simi-
larity to TbMP52 at the amino acid level, while TbMP48 has
41% identity and 60% similarity to TbMP52. Thus, L5701.8
appears to be an ortholog of TbMP52, while TbMP48 is a para-
log of TbMP52. Database searches for homology, motif searches,
a ProfileScan of the PROSITE database, and a search of the
BLOCKS database revealed no homologs of these proteins, nor
any functional motifs. Thus, these proteins appear to be novel.
Association of TbMP52 and TbMP48 with the RNA editing
complex. The association of the 45- and 48-kDa proteins with
the editing complex was assessed by immunoprecipitation,
since the cofractionation of these proteins with the editing ac-
tivity suggests that they may both be associated with the editing
complex. Recombinant TbMP52 (rTbMP52) and rTbMP48
proteins were expressed in E. coli with an N-terminal six-His
tag. Abundant expression of these proteins was evident as
bands in SDS-PAGE gels of IPTG-induced E. coli that stained
intensely with Coomassie blue (Fig. 7A). None of the MAbs
that we isolated after immunization with the purified editing
complex reacted with rTbMP48. However, Western analysis of
the recombinant proteins revealed that MAb P3C1-G2 specif-
ically reacts with rTbMP52 (Fig. 7B). This further confirms
that the TbMP52 gene encodes the protein identified by mass
spectrometry analysis of the ;49-kDa protein present in the
purified editing complex. This observation, along with the find-
ing that MAb P3C1-G2 specifically immunoprecipitates RNA
editing activity from the 20S mitochondrial fraction in high
FIG. 5. Immunofluorescence with MAb P3C1-G2, which is specific
for TbMP52. Procyclic T. brucei cells were stained with MAb (A) and
DAPI (B), showing the nucleus and smaller kinetoplast.
TABLE 1. SEQUEST output file of the TbMP52 CID spectrum
showing the correlation between peptides from the trypanosome
database and the observed peptide CID spectrum
(M1H)1 Scorea Databasereference Peptide sequence
c
2269.5 4.9026 7330318b (K)VHGTNFGIYLINQGDHEVVR
2268.7 2.7907 2K9.TV (S)IRTRLWKVIDVGCRRPVE
2267.7 2.6511 2312.TF (Q)SSSYITGEINLLVIRKVVKM*
2268.8 2.5782 4827345b (T)KKLRERQINFKKGSLPVLL
2269.8 2.5587 5119828b (K)SRKHMAHRIVLLGVINITPL
a Cross-correlation score.
b GenBank sequence identification number.
c *, modified methionine.
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KCl concentrations (Fig. 3B), shows that TbMP52 is tightly
associated with the RNA editing complex. Peptides corre-
sponding to both TbMP52 and TbMP48 were identified in the
immunoprecipitated editing complex by mass spectrometry
analysis (results not shown).
DISCUSSION
This study reports enrichment of the RNA editing complex
from T. brucei mitochondria and the identification of two genes
that encode 45- and 48-kDa (mature) proteins that are tightly
FIG. 6. (A) Alignment of predicted amino acid sequences of TbMP52 and related proteins TbMP48 and L5701.8. Potential N-terminal amino
acids are in bold. The TbMP48 gene sequence is from contig TRYP1.0.7383 of chromosome I (Sanger Center T. brucei database) and the L5701.8
ORF is from L. major chromosome 1 (20). The alignment indicates amino acids that are conserved (p), semiconserved (:), and partially conserved
( . ) among all these proteins. (B) Predicted amino acid sequence of TbMP48 showing the 12 tryptic peptides (two of which were contiguous) that
were identified by mass spectrometric analysis (underlined). The first N-terminal peptide (dashed underline) is nontryptic, and the 17 amino acids
at the N terminus (italicized) are a predicted mitochondrial targeting signal. (C) CID spectrum of the likely N-terminal peptide of TbMP48.
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associated with the editing complex. The complex was fraction-
ated by a combination of cation-exchange, anion-exchange,
and gel filtration chromatography followed by glycerol gradient
sedimentation using the in vitro deletion editing assay to mon-
itor purification. The enriched complex contains all of the
catalytic activities that are associated with editing. These in-
clude the gRNA-directed endoribonuclease, 39-TUTase, 39-
exouridylylase, and RNA ligase (and adenylylation) activities
that are predicted by models of the general mechanism of edit-
ing (2, 14, 26). A MAb that was prepared by using the enriched
complex is specific for both native and recombinant 48-kDa
protein and also immunoprecipitates the in vitro deletion ed-
iting activity as well as the associated catalytic activities.
The fractionation reported here differs from previously re-
ported purification of the editing complex (18, 24). This study
used in vitro editing to monitor purification rather than fol-
lowing purification of adenylylatable proteins. It also enriched
the complex sequentially with SP Sepharose (cation-exchange),
Q Sepharose (anion-exchange), and Superose 6 (gel filtration)
columns followed by sedimentation in a glycerol gradient. The
purification achieved could not be calculated based on specific
activity since the in vitro editing assay is not linear (our un-
published results). However, purification from cleared mito-
chondrial lysate is estimated to be ;8,500-fold based on pro-
tein recovery and substantially more based on total cellular
protein. The in vitro editing assays requires that all steps in
editing occur. The intent of the purification approach used in
this study was to select for the fully functional complex and to
avoid activities that may resemble but not be part of the editing
complex.
The complex that is fully functional in editing has an appar-
ent mass of 1,600 kDa, based on gel filtration chromatography,
and it sediments at ;20S. Several of the editing-associated ac-
tivities, such as endonuclease, TUTase, and RNA ligase activ-
ities, elute in a second peak with an apparent mass of 500 kDa
(Panigrahi et al., unpublished results). Madison-Antenucci et
al. (18) reported two complexes with masses of ;700 and ;450
kDa. The smaller masses may reflect the differences in isola-
tion protocol used in the study. In addition, the isolated
;1,600-kDa complex is capable of in vitro editing in the
present study, while this was not shown for the complex iso-
lated by Madison-Antenucci et al. (18). The complex isolated
here contained gRNAs and preedited mRNAs, similar to that
described by Madison-Antenucci et al. (18) but unlike the
complex reported by Rusche´ et al. (24).
The composition of the fully functional editing complex is
not known. The most purified fraction reported here contains
20 major proteins (Fig. 2) that together total 1,140 kDa, but at
least three of these proteins may be contaminants, and editing
complex proteins may not all be present in a 1:1 stoichiometry
(Panigrahi et al., unpublished). The most purified fraction re-
ported by Rusche´ et al. (24) contained eight major proteins,
and those authors suggested that three of the proteins may
represent RNA ligase based on their ability to be adenylylated.
The most purified fraction isolated by Madison-Antenucci et
al. (18) contained 13 major proteins. Since abundance of pro-
teins in a purified fraction is not definitive evidence that a
protein is a component of the editing complex, determination
of which are components of the complex will await indepen-
dent evidence. It seems unlikely that the fully functional edit-
ing complex contains only eight polypeptides, as suggested by
Rusche´ et al. (24). Those authors suggested that three of the
proteins may represent RNA ligase and that editing requires
proteins that perform the endoribonuclease, exouridylylase,
and TUTase functions. It is also likely that some proteins are
involved in RNA-RNA positioning, annealing, and unwinding
functions. Indeed, the complex isolated here contains gRNAs
and preedited mRNAs, indicating the presence of RNA bind-
ing proteins. A helicase activity appears to be associated with
RNA editing based on cofractionation (4) and experiments
showing that mitochondrial helicase null mutants have reduced
editing (19). Thus, helicase may be a component of the editing
complex, although not absolutely essential for editing. The
pre-mRNA and gRNA must be bound by the complex, perhaps
by the anchor duplex, and the 59 cleavage fragment must be
retained after cleavage by the endoribonuclease. It also seems
likely that proteins are needed to maintain the structure of the
editing complex in order to position the catalytic sites of the
editing enzymes and relocate the pre-mRNA and gRNA as
each site is edited.
Several proteins have been suggested to be components of
the editing complex based on approaches other than purifica-
FIG. 7. Expression of rTbMP48 and rTbMP52 with an N-terminal
six-His tag. (A) Coomassie blue-stained gel of total E. coli lysates
separated on SDS-PAGE showing protein size standards (M; sizes [in
kilodaltons] are on the left), uninduced cells (U), and cells 3 h after
induction with 1 mM IPTG (I). (B) Western analysis showing the
reaction of MAb P3C1-G2 with rTbMP52 (lane 2). E. coli cells ex-
pressing rTbMP48 (lane 1) were used as a negative control.
TABLE 2. SEQUEST output file for the CID spectrum of TbMP52
N-terminal peptide
(M1H)1 Scorea Database reference Peptide sequence
1037.1 3.9923 TRYP1.0.7383 (F)VGGDGSIFER
1037.2 2.9684 6A9.TR (V)VGGIGTTFER
1037.2 2.8651 1395223b (A)RFFEAGNVP
1037.1 2.7472 18L22.TF (R)VDDSGKMER
1037.1 2.7390 trypEf4.p1p (S)VDDAYM*IGH
a Cross-correlation score.
b GenBank sequence identification number.
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tion of the complex. Several proteins which specifically cross-
link to gRNA upon UV irradiation have been described. Read
et al. (23) demonstrated cross-linking of gRNA to 25- and
90-kDa proteins upon incubation with mitochondrial extract.
The 90-kDa protein was shown to be specific for oligo(U), as is
the case for the 16-kDa RBP16 (10) and the 75-kDa TBRGG1
(30). Allen et al. (1) identified a 55-kDa gRNA binding protein
in an enriched RNA editing fraction. Wang et al. (personal
communication) identified 50- and 70-kDa proteins in a par-
tially purified (sequential SP Sepharose- and Q Sepharose-
fractionated) editing complex fraction that specifically bind
gRNA. The roles of these proteins in RNA editing have not
been demonstrated. Indeed, while MAbs against gBP21, the
25-kDa protein that specifically binds gRNA, immunoprecipi-
tate editing activity, this immunoprecipitation is prevented by
micrococcal nuclease treatment (1), and gBP21 null mutants
perform editing normally (16). Thus, while it appears that
gBP21 is an RNA binding protein, its role in editing is uncer-
tain. It does not appear to be an essential component of the
editing complex and thus may have an accessory role, such as
bringing gRNA to the complex. Alternatively, it may have
precipitated editing activity simply based on its affinity for
RNA. The 110-kDa glutamate dehydrogenase specifically
cross-links to RNA in Leishmania tarentolae (3), but the knock-
out of the gene for this protein in T. brucei had no effect on
editing (5). The roles of the other RNA binding proteins have
not been tested. REAP1 was identified using MAbs made to an
;40S fraction from glycerol gradient fractionation of a mito-
chondrial lysate. This antibody recognizes proteins in the ;20S
and ;40S fractions, where in vitro editing is detected, and
upon incubation with the mitochondrial fraction, the antibody
inhibits in vitro insertion editing, suggesting that this protein
may be a functional component of the complex (18). At this
time, the role of REAP1 in RNA editing has not been deter-
mined.
The two proteins and corresponding genes that we identified
here using a combination of mass spectrometry and immuno-
precipitation and Western analyses are candidate components
of the editing complex. A MAb that was raised against the
purified native complex is specific for a 48-kDa protein that is
primarily localized in the 20S fraction in a glycerol gradient of
total cleared mitochondrial lysate (Fig. 3E), where editing pri-
marily sediments. The MAb also immunoprecipitates in vitro
deletion editing activity from the 20S fraction in addition to the
precleaved insertion editing, endonuclease, TUTase, 39-ex-
ouridylylase, and RNA ligase activities that are associated with
editing. Furthermore, it immunoprecipitates the adenylylation
activity and adenylylated proteins (Fig. 3C and D), which have
been suggested to be the editing-associated RNA ligases. The
immunoprecipitation was specific, since it occurred even in 400
mM KCl with 0.1% nonionic detergent and did not occur with
antibodies that do not react with proteins in the fraction which
contains the most in vitro editing activity. The 45-kDa protein
is related to the 48-kDa protein and also cofractionates with
the in vitro deletion editing activity. Both the 45- and 48-kDa
proteins were identified in the immunoprecipitated sample by
mass spectrometry (Panigrahi et al., unpublished). The genes
for each of these proteins predict a mitochondrial targeting
signal sequence, and TbMP52 was localized in mitochondria
using the MAb. Thus, taken together the evidence strongly
suggests that both proteins are associated with the editing
complex. TbMP52 is an ortholog of the L. major gene L5701.8
(20), which has no known function. Database searching found
no other homologs or functional motifs in the databases, and
thus we are not able to assign a function to these proteins.
Further biochemical and genetic studies on the roles of these
proteins in RNA editing are in progress. Preliminary results
suggest that TbMP52 has RNA ligase activity (Schnaufer et al.,
unpublished results).
Overall no protein has been shown to be essential for RNA
editing. Of the candidates identified to date, a functional as-
sociation with RNA editing has been demonstrated only for
RNA helicase, mHEL61p (19). While several other candidates
have been identified by a variety of approaches, functional
analyses such as knockout and genetic modification in vivo
have yet to show a definitive role in RNA editing or have yet
to be done. However, the list of candidates has increased and
the criteria for a possible role in editing have improved, sug-
gesting that functions in editing will be demonstrated for sev-
eral proteins in the near future. For example, what are the
specific functions of the individual protein components of the
complex, what is the structure of the editing complex and does
it have subunits, and what is the biogenesis of the editing
complex? Such studies are likely to make progress toward
answering these and other questions about the editing com-
plex.
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